MDB-68. DISCOVERING DRUG SENSITIVITIES IN MEDULLOBLASTOMA USING PATIENT- AND PDX-DERIVED TUMOROIDS
Chris Meulenbroeks(Princess Máxima Center), Marcel Kool(German Cancer Research Center), Jens Bunt(Princess Máxima Center), Benjamin Schwalm(German Cancer Research Center), Phylicia Stathi(Princess Máxima Center), Mariëtte E.G. Kranendonk(Princess Máxima Center), Stefan M. Pfister(Heidelberg University), Paul A. Northcott(St. Jude Children's Research Hospital), Eelco W. Hoving(Princess Máxima Center), Till Milde, Sabine Plasschaert(Princess Máxima Center), Anna Kołodziejczak(German Cancer Research Center), Norman Mack(German Cancer Research Center), Chio Carranza Villarejo(Princess Máxima Center), Neal Geisemeyer(German Cancer Research Center), Martine F. Roussel(St. Jude Children's Research Hospital), Julia Schüler(Charles River Laboratories (Germany)), Marc van de Wetering(Oncode Institute)
Cited by 2
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
|Cell|2002|2k
In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration
|Nature|2013|1.6k
Lgr5+ve Stem Cells Drive Self-Renewal in the Stomach and Build Long-Lived Gastric Units In Vitro
|Cell stem cell|2010|1.5k